Protein synthesis inhibitors: 30S vs 50S antibiotics
Sort protein synthesis inhibitors by ribosomal subunit and the step they block, then link each class to its signature adverse effect.
Chapters (12)
Classify protein synthesis inhibitors by ribosomal subunit and step blocked, and link each mechanism to its key adverse effect.
The short version
- Bacteria build proteins on a 70S ribosome (30S + 50S subunits); human cytosolic ribosomes are 80S, which is why these drugs are selective.
- A T at thirty, C C E L at fifty: aminoglycosides and tetracyclines bind 30S; chloramphenicol, clindamycin, erythromycin and the other macrolides, and linezolid bind 50S.
- Aminoglycosides cause misreading, are bactericidal, need oxygen-dependent uptake (so they miss anaerobes) and cause nephrotoxicity and ototoxicity.
- Tetracyclines block aminoacyl-tRNA at the A site, chelate calcium and stain developing teeth; macrolides block translocation and can prolong the QT interval.
- Each class has a signature adverse effect that follows from what the drug is, or where it goes.
Protein synthesis inhibitors: same machine, different drugs
A woman in her third trimester has a chest infection. Her doctor chooses azithromycin, not doxycycline, even though both stop bacteria from making protein. Same job, same machine. So why does the choice matter?
This lesson sorts the protein synthesis inhibitors by ribosomal subunit and by the step they block, and links each mechanism to its signature adverse effect. The pregnant woman is answered at the end.
The bacterial ribosome: 70S versus 80S
Bacteria build proteins on a 70S ribosome, made of a 30S subunit and a 50S subunit. Human cytosolic ribosomes are 80S, which is why these drugs are selective.[1][6]
Translation gives the drugs their targets. In order:
- An initiation complex forms.
- An aminoacyl-tRNA enters the A site.
- The peptidyl transferase joins the amino acids.
- The ribosome translocates.
Each drug class blocks one of these steps, or binds near it.[1]
30S vs 50S antibiotics: A T at thirty, C C E L at fifty
A memory aid sorts the drugs by subunit: A T at thirty, C C E L at fifty. It is a memory aid, not a sourced rule; the drug-to-subunit assignments themselves come from the references.[1]
| Subunit | Letters | Drugs |
|---|---|---|
| 30S | A T | Aminoglycosides, tetracyclines |
| 50S | C C E L | Chloramphenicol, clindamycin, erythromycin and the other macrolides, linezolid |
The 30S drugs: aminoglycosides and tetracyclines
Aminoglycosides, such as gentamicin, bind the 16S RNA near the A site. They make the ribosome misread the message and stop early, and they are bactericidal.[1][10]
They enter bacteria by oxygen-dependent transport, so they do not work against anaerobes.[1] They also accumulate in kidney tubule cells and inner-ear hair cells, which is why they cause nephrotoxicity and ototoxicity.[2]
Tetracyclines stop the aminoacyl-tRNA from binding to the A site, and they are bacteriostatic.[1][10]
They chelate calcium, so dairy and antacids reduce their absorption.[10] They also stain developing teeth, so they are avoided in pregnancy and in young children.[3][10]
The 50S drugs: macrolides, chloramphenicol, clindamycin and linezolid
Macrolides block translocation, and they are bacteriostatic.[1][4] They can prolong the QT interval, and erythromycin and clarithromycin inhibit CYP3A4, raising levels of other drugs.[4][5]
Chloramphenicol blocks the peptidyl transferase. It can suppress the bone marrow, because it also inhibits protein synthesis in mitochondria, and in newborns it can cause gray baby syndrome.[6][7]
Clindamycin and linezolid also bind the 50S subunit; linezolid blocks initiation.[1][8] Linezolid's signature adverse effect is bone marrow suppression.[9]
Signature adverse effects: why they follow the drug
These drugs hit the same machine, yet their signature adverse effects differ. The step they block in bacteria does not predict the effect: each effect follows from what the drug is, or where it goes in the body (for chloramphenicol, into human mitochondria).
| Class | Subunit and step | Signature adverse effect |
|---|---|---|
| Aminoglycosides | 30S; misreading near the A site; bactericidal | Nephrotoxicity and ototoxicity |
| Tetracyclines | 30S; block aminoacyl-tRNA at the A site; bacteriostatic | Teeth staining; chelated by calcium (dairy, antacids reduce absorption) |
| Macrolides | 50S; block translocation; bacteriostatic | QT prolongation, CYP3A4 inhibition (erythromycin, clarithromycin) |
| Chloramphenicol | 50S; peptidyl transferase | Marrow suppression, gray baby syndrome |
| Linezolid | 50S; blocks initiation | Bone marrow suppression |
Putting it to use: an abscess and the pregnant woman
A patient with an abdominal abscess full of anaerobes fails gentamicin alone. The drug never gets in: anaerobes lack the oxygen-dependent uptake.[1]
Back to the woman in her third trimester. Doxycycline is a tetracycline, so we avoid it because it can stain the baby's developing teeth.[3] Azithromycin is a macrolide and is not avoided for that reason.
Practice question
Original · USMLE styleA 62-year-old woman is treated for gram-negative bacteremia from pyelonephritis with an intravenous antibiotic. On day 8, her serum creatinine has risen from 0.9 mg/dL to 1.8 mg/dL, and she reports ringing in her ears and hearing loss.
Common questions
Which antibiotics are 30S and which are 50S protein synthesis inhibitors?
Aminoglycosides and tetracyclines bind the 30S subunit. Chloramphenicol, clindamycin, erythromycin and the other macrolides, and linezolid bind the 50S subunit. The memory aid is A T at thirty, C C E L at fifty.
Why are protein synthesis inhibitors selective for bacteria?
Bacteria use a 70S ribosome made of 30S and 50S subunits, while human cytosolic ribosomes are 80S. The drugs act selectively on the bacterial ribosome.
Why are tetracyclines avoided in pregnancy and young children?
Tetracyclines bind calcium in developing teeth and can stain them permanently, so they are avoided in pregnancy and in young children. Separately, calcium in dairy and antacids reduces their absorption.
Why do aminoglycosides not work against anaerobes?
They enter bacteria by oxygen-dependent transport, and anaerobes lack this uptake, so the drug never gets in.
What are the signature adverse effects of macrolides and chloramphenicol?
Macrolides can prolong the QT interval, and erythromycin and clarithromycin inhibit CYP3A4. Chloramphenicol can suppress the bone marrow and, in newborns, can cause gray baby syndrome.
Transcript
Read the full narration, by chapter613 words
0:00The hook: azithromycin or doxycycline in pregnancy?
A woman in her third trimester has a chest infection. Her doctor chooses azithromycin, not doxycycline, even though both stop bacteria from making protein. Same job, same machine. So why does the choice matter? Today: sort protein synthesis inhibitors by ribosomal subunit and step blocked, and link each mechanism to its signature adverse effect.
0:24The ribosome: 70S bacteria vs 80S human, and the translation steps
Bacteria build proteins on a 70S ribosome, made of a 30S subunit and a 50S subunit. Human cytosolic ribosomes are 80S, which is why these drugs are selective. In translation, an initiation complex forms, an aminoacyl-tRNA enters the A site, the peptidyl transferase joins amino acids, and the ribosome translocates.
0:50A memory aid: A T at thirty, C C E L at fifty
A memory aid: AT at 30, CCEL at 50. That is aminoglycosides and tetracyclines at 30. Chloramphenicol, clindamycin, erythromycin and the other macrolides, and linezolid, at 50.
1:07Aminoglycosides: misreading, no anaerobes, kidney and ear toxicity
Start with the 30S drugs. Aminoglycosides, such as gentamicin, bind the 16S RNA near the A site. They make the ribosome misread the message and stop early, and they are bactericidal. They enter bacteria by oxygen-dependent transport, so they do not work against anaerobes. And they accumulate in kidney tubule cells and inner-ear hair cells, which is why they cause nephrotoxicity and ototoxicity.
1:38Tetracyclines: A site block, calcium chelation, teeth staining
Tetracyclines stop the aminoacyl-tRNA from binding to the A site, and they are bacteriostatic. They chelate calcium, so dairy and antacids reduce their absorption, and they stain developing teeth, so they are avoided in pregnancy and in young children.
1:56Macrolides: translocation, QT prolongation, CYP3A4
Now the 50S drugs. Macrolides block translocation, and they are bacteriostatic. They can prolong the QT interval, and erythromycin and clarithromycin inhibit CYP3A4, raising levels of other drugs.
2:13Chloramphenicol, clindamycin and linezolid
Chloramphenicol blocks the peptidyl transferase. It can suppress the bone marrow, because it also inhibits protein synthesis in mitochondria, and in newborns it causes gray baby syndrome. Clindamycin and linezolid also bind the 50 S subunit; linezolid blocks initiation.
2:33Putting it to use: an abscess and the pregnant woman
Now use it. A patient with an abdominal abscess full of anaerobes fails gentamicin alone. The drug never gets in: anaerobes lack the oxygen-dependent uptake. And back to our pregnant woman: doxycycline is a tetracycline, so we avoid it because it can stain the baby's developing teeth; azithromycin is a macrolide and is not avoided for that reason.
2:58Your turn: practice question
Your turn. A 62-year-old woman is treated for gram-negative bacteremia from pyelonephritis with an intravenous antibiotic. On day eight, her creatinine has risen from 0.9 to 1.8 milligrams per decilitre, and she reports ringing in her ears and hearing loss. Which of the following best describes the mechanism of the drug most likely responsible? A, binds the 30S subunit and causes misreading of messenger RNA. B, binds the 30S subunit and blocks aminoacyl-tRNA entry at the A site. C, binds the 50S subunit and blocks translocation. D, binds the 50S subunit and inhibits peptidyl transferase. E, binds the 50S subunit and blocks initiation complex formation.
3:53Pause, then the wrong options
Pause here and decide. B is out: that is a tetracycline, whose signature problems are tooth staining and chelation of calcium. C is out: that is a macrolide, whose signature problems are QT prolongation and drug interactions. D is out: that is chloramphenicol, whose signature problem is bone marrow suppression. E is out: that is linezolid, whose signature problem is bone marrow suppression, not this kidney and ear picture.
4:26The answer: A
So the answer is A. Aminoglycosides bind the 30S subunit, cause misreading, and concentrate in kidney and inner-ear cells, so the toxicity fits.
4:38High-yield recap
Three things to keep. One: AT at 30, CCEL at 50. Two: aminoglycosides misread the message, and cause kidney and ear toxicity. Three: each class has a signature adverse effect that follows from what it is, or where it goes. That completes this set of drug mechanisms, so go back over the questions until the reasoning feels automatic.
Sources
Numbers in the text, e.g. [1], point here- Action and resistance mechanisms of antibiotics: a guide for clinicians. PMC5672523. pmc.ncbi.nlm.nih.gov/articles/PMC5672523/
- Aminoglycoside-induced cochleotoxicity. PMC5640705. pmc.ncbi.nlm.nih.gov/articles/PMC5640705/
- Systemic minocycline side effects: review. PMC8300648. pmc.ncbi.nlm.nih.gov/articles/PMC8300648/
- Macrolide cardiac arrhythmias review. PMC12191034. pmc.ncbi.nlm.nih.gov/articles/PMC12191034/
- Macrolides and CYP3A4 inhibition (erythromycin, clarithromycin; azithromycin weak). PMC13264458. pmc.ncbi.nlm.nih.gov/articles/PMC13264458/
- Chloramphenicol bone marrow cytotoxicity. PMC11626822. pmc.ncbi.nlm.nih.gov/articles/PMC11626822/
- Navigating antibacterial frontiers. PMC11091902. pmc.ncbi.nlm.nih.gov/articles/PMC11091902/
- Oxazolidinones and initiation complex formation. PMC13655609. pmc.ncbi.nlm.nih.gov/articles/PMC13655609/
- Linezolid adverse events pharmacovigilance study. PMC10904462. pmc.ncbi.nlm.nih.gov/articles/PMC10904462/
- Wikipedia: Protein synthesis inhibitor; Aminoglycoside; Tetracycline antibiotics; Macrolide; Chloramphenicol; Clindamycin; Linezolid (opened 13 Nov 2026).
The practice question is original and its patient is synthetic. Every fact is checked against the sources above in independent accuracy reviews. Always follow your local guidelines and your own laboratory’s ranges.
Image credits. Illustrations: Servier Medical Art (smart.servier.com), CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/), adapted (cropped, recoloured, outlined): pregnant woman, ribosome subunits (recoloured blue, orange and grey), kidney, inner ear, milk glass, child's teeth (grey stain overlay added by us, illustration only), newborn. Bone marrow: NIAID NIH BioArt Source, public domain. The tRNA, mRNA, drug blocks, QT strip, cells, abscess, creatinine chart, question card, pocket card and all handwriting are drawn in code (original). No AI-generated teaching images.
Corrections. None so far. Spotted an error? Email info@medservatory.com with the lesson code MS-S1-PHARM-015.
For exam study only, not medical advice. Read the medical disclaimer.
In this series
Playlist on YouTube- EP 01Potency vs efficacy: EC50, Emax and agonist types5:17
- EP 02Competitive vs noncompetitive antagonists: effect on EC50 and Emax5:01
- EP 03Therapeutic index explained: TD50 / ED505:01
- EP 04First-pass metabolism and bioavailability: calculating oral F from AUC5:18
- EP 05Volume of distribution: why Vd can be bigger than the body5:17
- EP 06Clearance and half-life: t½ = 0.693 × Vd / CL5:01
- EP 07Zero-order vs first-order elimination explained5:12
- EP 08Loading dose and maintenance dose, explained5:02
- EP 09CYP450 inducers and inhibitors: how they change drug levels5:16
- EP 10Autonomic receptors: alpha, beta and muscarinic5:33
- EP 11Beta blocker selectivity: beta-1, ISA and alpha blockade5:24
- EP 12Vasopressors compared: receptors, pressure and heart rate5:46
- EP 13Organophosphate poisoning: muscarinic vs nicotinic signs5:36
- EP 14Receptor desensitization, downregulation and upregulation5:01
- EP 15Beta-lactams and vancomycin: enzyme versus substrate5:04
- EP 16Protein synthesis inhibitors: 30S vs 50S antibiotics5:07